Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01682837 · ClinicalTrials.gov registry record · Phase 2
Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT01682837: Completed Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
NCT01682837 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 35 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01682837, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.
Primary Outcome
This is the average systolic blood pressure over a 24 hour period.
Interventions
- DRUG Placebo
- DRUG Potassium chloride powder
- DRUG Potassium citrate powder
- DRUG Potassium magnesium citrate powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
What the finished NCT01682837 record still lists
NCT01682837 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01682837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01682837 about?
NCT01682837 is a clinical study titled "Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension". Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.
What is the current status of trial NCT01682837?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2012-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01682837?
The interventions under investigation include: Placebo (DRUG), Potassium chloride powder (DRUG), Potassium citrate powder (DRUG), Potassium magnesium citrate powder (DRUG).
Who is sponsoring clinical trial NCT01682837?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01682837's enrollment target sits among peer trials
35 1524th of 2000 higher than 462 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia